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Transcriptional reprogramming in macrophage multinucleation 
 
ABBREVIATIONS 
MM : macrophage multinucleation 
MGCs: multinucleated giant cells 
NTN : nephrotoxic nephritis 
BMDM : bone marrow derived macrophages 
FDR : false discovery rate 
TF: transcription factor 




Macrophage multinucleation (MM) is essential for various biological processes such as osteoclast-mediated 
bone resorption and multinucleated giant cell-associated inflammatory reactions. Here we study the 
molecular pathways underlying multinucleation in the rat through an integrative approach combining MS-
based quantitative phosphoproteomics (LC-MS/MS) and transcriptome (high throughput RNA-sequencing) 
to identify new regulators of MM. We show that a strong metabolic shift towards HIF1-mediated glycolysis 
occurs at transcriptomic level during MM, together with modifications in phosphorylation of over 50 
proteins including several ARF GTPase activators and polyphosphate inositol phosphatases. We use shortest-
path analysis to link differential phosphorylation with the transcriptomic reprogramming of macrophages and 
identify LRRFIP1, SMARCA4 and DNMT1 as novel regulators of MM. We experimentally validate these 
predictions by showing that knock-down of these latter reduce macrophage multinucleation. These results 
provide a new framework for the combined analysis of transcriptional and post-translational changes during 
macrophage multinucleation, prioritizing essential genes and revealing the sequential events leading to the 
multinucleation of macrophages.  
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INTRODUCTION 
Macrophage multinucleation (MM) occurs when multiple macrophages fuse to form a single cell containing 
multiple nuclei. This phenomenon plays an essential role in several homeostatic and pathological processes. 
In healthy subjects, macrophage multinucleation is required for the formation of osteoclasts able to resorb 
bone excesses and maintain bone homeostasis (1, 2). Macrophage multinucleation also plays a major role in 
inflammatory conditions such as sarcoidosis or tuberculosis through the formation of multinucleated giant 
cells (MGCs), effector cells of granulomatous reaction (3, 4). 
 
Despite the central role of MM in various biological mechanisms, the basic knowledge of its molecular 
determinants and the pathways regulating multinucleation remain largely unexplored. Moreover the 
presence of common regulators of both MGCs and osteoclasts formation suggests the existence of common 
mechanisms for macrophage multinucleation across different cell types (5–8). Cell multinucleation was 
previously investigated at a transcriptional level in osteoclasts (9) and fusing rat alveolar macrophages (10). 
This led to the identification of novel determinants of osteoclast multinucleation (11) and macrophage fusion 
(10).  
 
The Wistar-Kyoto (WKY) strain has been extensively used for its unique susceptibility to nephrotoxic 
nephritis (NTN), a highly reproducible and macrophage-dependent model of experimentally induced 
crescentic glomerulonephritis which has a large genetic component (12–14). The NTN in the WKY rat is 
also characterized by the formation of glomerular MGCs but the specific role of these cells in the progression 
of the disease remains to be determined. We observed that when the bone marrow derived macrophages 
(BMDMs) from the NTN-susceptible WKY rats are cultured in vitro under normal conditions, they 
spontaneously form MGCs after 3 days as opposed to NTN-resistant Lewis (LEW) BMDMs which show very 
little fusion (Figure 1A). We used this in vitro model of spontaneous multinucleation of BMDMs to identify 
a new major determinant of spontaneous macrophage multinucleation in a back-cross population derived 
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from WKY and LEW rats (15) as well as recapitulating previously known genes (DCSTAMP (8), MMP9 
(16)) as part of a macrophage gene regulatory network. 
  
Here, we developed an integrative approach to identify and characterize pathways involved in macrophage 
multinucleation by taking advantage of strain dependent spontaneous formation of MGCs during 
macrophage differentiation. We combined genome-wide and label-free phosphoproteome by LC-MS/MS 
and transcriptome by RNA-sequencing (RNA-seq) to pinpoint the cellular pathways as well as key regulators 
of transcriptomic changes occurring during macrophage multinucleation. We provide a first account of the 
interplay between posttranslational and transcriptomic modifications occurring during macrophage 




RNA isolation and RNA-seq library preparation in primary macrophages 
Total RNA was extracted from WKY and LEW bone-marrow derived macrophages at the indicated time 
points during differentiation (day3 and day5) using Trizol (Invitrogen) according to manufacturer's 
instructions with an additional purification step by on-column DNase treatment using the RNase-free DNase 
Kit (Qiagen) to ensure elimination of any genomic DNA. The integrity and quantity of total RNA was 
determined using a NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific) and Agilent 2100 
Bioanalyzer (Agilent Technologies). 1μg of total RNA was used to generate RNA-seq libraries using TruSeq 
RNA sample preparation kit (Illumina) according to the manufacturer's instructions. Briefly, RNA was 
purified and fragmented using poly-T oligo-attached magnetic beads using two rounds of purification 
followed by the first and second cDNA strand synthesis. Next, cDNA 3' ends were adenylated and adapters 
ligated followed by 10 cycles of library amplification. Finally, the libraries were size selected using AMPue 
XP Beads (Beckman Coulter) purified and their quality was checked using Agilent 2100 Bioanalyzer. 
Samples were randomized to avoid batch effects and libraries were run on a single lane per sample of the 
HiSeq 2000 platform (Illumina) to generate 100bp paired-end reads. An average of 72M reads coverage per 
sample was achieved (minimum 38M) 
RNA-seq data analysis 
RNA-seq reads were aligned to the rat (rn4) reference genome using tophat 2. The average number of 
mapped was 67M (minimum 36M) corresponding to an average mapping percentage of 93%. Sequencing 
and mapping were quality controlled using standard tools provided in the fastQC software. Gene level read 
counts were computed using HT-Seq-count with ‘union’ mode (17) and genes with less than 10 aligned 
reads across all samples were discarded prior to analysis leading to 15,155 genes. Clustering of samples 
corresponding to different conditions was done using ward’s methods based on Euclidian distance of scaled 
sample gene expression profile. Differential expression analyses between groups were conducted using 
edgeR (18) within each strain and time point using a 5% FDR for each comparison. In order to identify 
significant differences in gene expression variation across time-points between the WKY and LEW BMDMs, 
 6 
a generalized linear model was fitted on all samples including strain, time point and the [(strain) x (time 
point)] interaction term. The potential interaction was then tested using a Likelihood Ratio test (comparing 
to a model without the interaction term).  
The giant cell specific signature was defined as the set of genes that fulfilled the following criteria:  
(i) Significant Interaction between strain and time point at 5% FDR;  
(ii) Over-expression at day 5 compared to day 3 in WKY at 5% FDR; 
(iii) No differential expression at 5% nominal P-value in LEW between day 3 and day 5; 
(iv) Over-expression at day 5 in WKY compared to LEW at 5% FDR. 
Quantification of macrophage multinucleation, RNAi and qRT-PCR  
Rat bone marrow derived macrophages (BMDMs) were cultured as previously described (14). BMDMs 
were flushed from femur and tibia bones from rats and cultured in presence of L929-conditioned media for 
the indicated times in Lab-Tek chambers (Fisher Scientific, UK). To assess spontaneous MGC formation, 
macrophages were fixed at the indicated times using Reastain Quick Diff and MGC quantification was 
performed by counting the number of nuclei in 100 macrophages using light microscopy. To evaluate the 
effect of siRNA knockdown on macrophage multinucleation, WKY BMDMs were transfected for 48 hours 
with siGENOME SMARTpool for either rat Lrrfip1 or Smarca4 or Dnmt1 (100 nM, Dharmacon). All 
transfections were performed in parallel with siGENOME non-targeting siRNA pool as the scrambled 
control siRNA using Dharmafect 1 (1:50, Dharmacon) as a transfection reagent in OPTIMEM medium 
(Invitrogen). The siRNA sequences used in the siGENOME SMARTpool for all transcripts are available 
upon request. All qRT-PCRs were performed with a Viaa 7 Real-Time PCR system (Life technologies). . A 
two-step protocol was used beginning with cDNA synthesis with iScript select (Bio-Rad) followed by PCR 
using SYBR Green Jumpstart Taq Ready Mix (Sigma). A total of 10ng of cDNA per sample was used. All 
samples were amplified using a set of at least 4 biological replicates with three technical replicates used per 
sample in the PCR. Viia 7 RUO Software was used for the determination of Ct values. Results were 
analysed using the comparative Ct method and each sample was normalised to the reference gene Hprt, to 
account for any cDNA loading differences. The primer sequences are available upon request. 
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Macrophage phosphoproteome and proteome: cell lysis, protein digestion peptide and phosphopeptide extraction 
Cells in the flasks were washed twice with cold PBS supplemented with phosphatase inhibitors (1 mM 
Na3VO4; 1mM NaF) and lyzed in urea lysis buffer (8M Urea in 20 mM HEPES pH 8.0) supplemented with 
phosphatase inhibitors (1mM Na3VO4; 1mM NaF; 1 mM β-glycerol-phosphate; 2.5 mM Na4P2O7; 1 μM 
okadaic acid). Cell extracts were then scraped from the flasks, transfer to 2 mL low protein binding 
eppendorf tubes and further homogenized by sonication (3 pulses of 15 sec). Insoluble material was removed 
by centrifugation at 20,000 x g for 5 min at 4°C and proteins in the supernatants were quantified by 
Bradford. A total amount of 500 μg and 200 μg of protein/sample were reduced and alkylated by sequential 
incubation with 10 mM DTT and 10 mM Iodoacetamide for 15 min at room temperature for 
phosphopeptides and whole peptides, respectively. 20 mM HEPES pH 8.0 was used to reduce urea 
concentration to 2 M and proteins were digested overnight at 37°C with Immobilized tosyl-lysine 
chloromethyl ketone (TLCK)–trypsin [20 p-toluenesulfonyl-L-arginine methyl ester (TAME) units/mg]. 
Digestion was stopped by adding trifluoroacetic acid (TFA) to 1% final concentration and trypsin beads were 
removed by centrifugation. Peptide mixtures were then desalted by reverse phase chromatographic 
cartridges (Oasis HLB, Waters Corporation), washed and dried.  
For quantitative phosphoproteomics, phosphopeptides were enriched following a procedure previously 
described, with some modifications (19). Briefly, sample volumes after elution from Oasis cartridges were 
adjusted to 1 ml with glycolic acid solution (1 M Glycolic acid; 80% ACN; 5% TFA) and 50 μl of TiO2 
beads (50% slurry in 1% TFA) were added to the peptide mixture. After 5 min incubation at RT with 
rotation, TiO2 slurry was packed into preconditioned empty spin tips by centrifugation. Spin tips were 
conditioned with 200 μl of 100% ACN. TiO2 beads were sequentially washed with 200 μl of glycolic acid 
solution, 100 mM Ammonium acetate in 25% ACN and 1% ACN. Phosphopeptides were then eluted four 
times with 50 μl of 5% NH4OH in 1% ACN. Following the removal of the insoluble material by 
centrifugation from the eluents, supernatants were snap frozen in dry ice for 15 min. Samples were dried in 
a speed-vac and stored at -80°C for mass spectrometry. For quantitative proteomics, mass spectrometry was 
 8 
applied without TiO2 enrichement only on WKY and LEW BMDM whole peptide extracts (analysed in 
technical duplicates) at the peak of multinucleation. For quantitative phosphoproteomics, each of the 4 
samples was provided in biological triplicate (in single technical replicate) for mass spectrometry analysis.  
Mass Spectrometry 
Phosphopeptide and whole peptide dried extracts were re-suspended in 14 μl of reconstitution buffer (0.1% 
TFA containing 20 nM of an enolase digest) and 4 μl (phosphopeptides) and 5 μl (peptides) were loaded in a 
LC-MS/MS system. This consists of a nanoflow liquid chromatography (nanoLC, Ultimate 3000, Thermo 
Scientific) system coupled online to an LTQ-Orbitrap Velos mass spectrometer (Thermo Scientific). The 
nanoLC system delivered a flow of 8 µl/min (loading) onto a trap column (Thermo Scientific Acclaim 
Pepmap 100 with dimensions 100µm internal diameter & 2cm length, C18 reverse phase material with 5µm 
diameter beads & 100Å pore size) in 98% water, 2% acetonitrile, 0.1% TFA. Peptides were then eluted on-
line to an analytical column (Thermo Scientific Acclaim Pepmap RSLC with dimensions 75µm internal 
diameter & 25cm length, C18 reverse phase material with 2µm diameter beads & 100Å pore size) & 
separated using a gradient with conditions: initial 5 minutes with 4% B (96% A), then 120 minute gradient 
4-35% B, then 10 minute isocratic at 100% B, then 5 minute isocratic at 4% B (solvent A: 98% water, 2% 
acetonitrile, 0.1% formic acid; solvent B: 20% water, 80% acetonitrile, 0.1% formic acid).  
For phosphopeptide quantification, a LTQ-Orbitrap Velos mass spectrometer acquired full scan survey 
spectra (m/z 350-1500) with a 15,000 resolution at m/z 400. A maximum of the 7 (phosphopeptides) most 
abundant multiply-charged ions registered in each survey spectrum were selected in a data-dependent 
manner, fragmented by collision induced dissociation (multi-stage activation enabled) with a normalized 
collision energy of 35% and scan in the LTQ (m/z 50-2000). This produced a duty cycle of 2.4 sec. A 
dynamic exclusion was enabled with the exclusion list restricted to 500 entries, exclusion duration of 60 sec 
and mass window of 10 ppm. Chromatographic peaks were about 30 sec at the base which ensured at least 
10 data points per extracted ion chromatogram (XIC). 
For whole protein quantification, a Q Exactive mass spectrometer acquired full scan survey spectra (m/z 
400-2000) with 70,000 resolution at m/z 400 was used. A maximum of the 12 most abundant multiply-
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charged ions registered in each survey spectrum were selected in a data-dependent manner, fragmented by 
higher-energy collision induced dissociation (HCD) with a normalized collision energy of 28%. This 
produced a duty cycle of approximately 1.5 seconds. MS/MS resolution was 17,500.  
 
Phosphopeptide and peptide (protein) identification 
For phosphopeptide identification, Mascot Distiller v2.4.3.1 was used to smoothen and centroid the MS/MS 
data and Mascot v2.4.1 search engine was used to match peaks to peptides in proteins present in the 
SwissProt Database (SwissProt_2013Jan.fasta) restricted to rattus norvegicus entries (7,853 sequences) (20). 
The process was automated with Mascot Daemon v2.4, mass tolerance was set to 10 ppm and 600 millimass 
units for precursor and fragment ions, respectively. Phosphorylation on Ser, Thr, and Tyr; PyroGlu on N-
terminal Glu; and oxidation of Met were allowed in the search as variable modifications and 
carbamidomethyl Cys as fixed modification. Trypsin (cleaves C-terminal to Arg and Lys residues provided 
there is not a Pro C-term to the Arg/Lys residue) was selected as the digestion enzyme and 2 missed 
cleavages were allowed. Sites of modification are reported when they had delta scores >10. Delta scores 
were calculated as previously described (21). Otherwise the site of modification was deemed to be 
ambiguous; in such cases phosphopeptides are reported as the start-end residues within the protein sequence. 
Results from Mascot searches were deposited into the ProteomeXchange Consortium 
(http://proteomecentral.proteomexchange.org) via the PRIDE partner repository (22) with the dataset 
identifier Project accession PXD001269 and Project DOI: 10.6019/PXD001269. Phosphopeptides showing 
a Mascot expectancy of <0.05 (~2% false discovery rate as assessed by searches against a decoy database) 
were placed in a database of peptides quantifiable by MS. In cases where a given peptide sequence matched 
more than one database entry, all such entries were listed in the final result table (Supplementary Table 
1). Pescal software (19, 23) was used to construct XICs of peptides included in the database across all the 
samples being compared. Enolase peptides spiked in all samples were used as reference points along 
chromatograms to align retention times. The XIC windows were 7 ppm and 2 min.  
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For quantitative proteomics, raw data files were uploaded onto Progenesis QI for Proteomics software 
(Nonlinear Dynamics, 2014, version: 2.0.5387.52102). Chromatographic alignment (with additional 
manual manipulation), data normalisation and peak picking were performed by Progenesis QI. Mascot 
server (version 2.5.0) was used for peptide/protein identification as searched against the Uniprot Swissprot 
rattus norvegicus FASTA (downloaded June 6th 2014) which contained 7,914 sequences. Mass tolerance was 
set to 5 ppm and 25 millimass units for precursor and fragment ions, respectively. Deamidation of Asn and 
Gln, PyroGlu on N-terminal Glu, and oxidation of Met were allowed in the search as variable modifications 
and carbamidomethyl on Cys as fixed modification. Trypsin was selected as the digestion enzyme and 2 
missed cleavages were permitted. All peptides used in quantification were exported from Mascot at identity 
threshold with p value 0.05. The overall search FDR was 1.3%. 
Differential Phosphorylation analysis 
Peak height intensity XIC values were log transformed and normalized to using PQN normalization (24). 
For each pair of condition, differential expression was assessed both quantitatively and qualitatively. Only 
peptides with at least 2 observations in each condition were considered for the quantitative analysis. 
Quantitative assessment of differential phosphorylation was assessed using a slightly modified version of the 
framework proposed in (25) .Briefly, in keeping with (25), we assume that peptide expression is missing 
with a probability that depends on both the true expression of the peptide (data is missing when the true 
expression is under a peptide-dependent threshold ci) and the sample specific probability of missing data 
(sample dependent-probability πl  to be missing at random). Similarly to (25), the censoring threshold ci is 
set for each peptide at the minimal observed a value across all samples (Maximum likelihood estimator) and 
the πl are estimated by modeling the occurrence of missing values as a function of the mean expression of the 
peptides. However, opposite to Karpievitch, for each individual l we model the probability of not observing 
a peptide as a parametric function of the mean  of the peptide in all samples from the same condition: 
P(missing |  ) = πl +(1- πl).(1-[(-al)/bl]), 
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where πl represents the probability of missingness at random (probability of missing expression 
measurement for a peptide with infinitely high expression). We then estimate the parameters πl [0,1], al 
and bl>0 via likelihood maximization. The use of a parametric fit to estimate the probability of missing 
values rather than the non-parametric estimate proposed by Karpievitch et al is justified here by the fact the 
non-parametric estimate led to unrealistic values (πl < 0) due to the unconstrained interpolation that was 
performed. Our estimate on the other hand, enforces strictly positive values of πl thus allowing more 
reliable estimates of the missing-at-random probability πl. 
P-values resulting from the quantitative models were adjusted for multiple testing using Benjamini-Hochberg 
correction and a 5% FDR threshold as used for significance.  
Differential Protein abundance 
For each biological replicate, values of protein abundance exported from Mascot were averaged between 
technical replicates to yield the final measures of protein abundance. Protein abundances were then log 
transformed (adding an offset of 1 to avoid infinite values) and samples intensities were scaled to have 
identical total intensity. For each protein, differential protein abundance between WKY and LEW was 
assessed using a t-test. 
Giant-cell specific phosphorylation signature 
Giant-cell specific phosphorylation signature was defined based on peptides that were detected in at least 2 
samples in all conditions. In order to improve power of the enrichment analysis (see below) we used non-
conservative statistical thresholds to identify giant-cell specific phosphorylation signature. While this 
approach might yield increased false positives, this will not bias the subsequent enrichment analysis since 
false positives will by definition occur at random. In detail, phosphopeptides were considered as exhibiting 
giant-cell specific signature if they fulfilled any of the two following set of criteria (see also Supplementary 
Figure 4): 
(1) WKY specific difference between time points: 
(i)  Differentially phosphorylated in WKY between day 3 and day 5 at a 5% FDR; 
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(ii) Not differentially phosphorylated in LEW between day 3 and day 5 at 5% nominal P-value; 
(iii)  Differentially phosphorylated in WKY compared to LEW at day 5 at 5% nominal P-value. 
(2) Day 5 specific difference between strains: 
(i) Differentially phosphorylated in WKY compared to LEW at day 5 at a 5% FDR; 
(ii) Not differentially phosphorylated WKY compared to LEW at day 3 at 5% nominal P-value; 
(iii)  Differentially phosphorylated in WKY compared to LEW at day 5 at 5% nominal P-value. 
In both cases the 3rd criteria (iii) was used as a mean to remove phosphopeptides exhibiting the wrong trends 
rather than as a statistical test, hence the decision not to account for multiple testing and use nominal P-
values < 0.05. 
In addition to the peptides selected by the procedure described above, we included phospho-peptides that 
were considered specifically absent/present in MGC (i.e., in WKY at D5). Specifically, a phosphorylated 
peptide was declared as detected above background when it was quantified and showed an log2(intensity) (i.e. 
area under curve) above 8 (empirically determined). Peptides where then considered as specifically present 
in MGC if they were detected above background in all 3 WKY D5 samples and in none of the other sample. 
Conversely, they were considered as specifically absent from MGC if they showed the opposite pattern (see 
Supplementary Figure 5).  
Phosphopeptide enrichment analysis 
Enrichment analysis of phosphopeptides was carried out by DAVID (26) using UniprotKb IDs and taking all 
phosphoproteins (retrieved from UniProtKb using keywords Phosphoprotein [KW-0597] and Organism: 
Rat [10116]) as a reference set.  
Transcription Factor Binding Site Enrichment 
131 transcription factors binding sites (TFBS) motifs were retrieved from the Jaspar Core vertebrate 
database and a Transcription Factor (TF) to gene binding affinity was computed for each gene on the genome. 
For each gene, the gene promoter was defined as a 1000bp wide window centered on the transcription start 
site (TSS) and the promoter sequence was extracted from the rn4 reference genome sequence. 
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When more than one TSS existed for a gene, only the promoter sequence around the first TSS was used to 
avoid biasing affinities toward genes with multiple TSS. Each promoter was then scored using TRAP (27) 
and PASTAA (28) was used to compute enrichment TFBS site among the genes identified from of the giant 
cell specific transcriptome analysis.  For LRRFIP1, a motif was build from the consensus sequence given in 
(29) by fixing an arbitrary 90% probability on each nucleotide of the consensus sequence and equal 
probability for all other nucleotides.  
Functional enrichment of predicted targets of transcription factors 
To assess the functional enrichment of the targets of each MGC specific transcription factor, we considered 
the top 1000 genes (genome wide) whose promoter had the highest binding affinity to the transcription 
factor according to TRAP predictions of transcription factor binding affinity (using a 1000 bp promoter 
around the TSS). Among these 1000 putative targets, we extracted the subset that was specifically up-
regulated in WKY at day 5, and considered these genes as putative targets of the MGC specific transcription 
factors. We then used DAVID to test functional enrichment of these genes.  
PPI network analysis 
We used 118,363 known physical interactions from the Biogrid database (Human PPI network, version 3.2, 
as retrieved on 31st October 2013) (removing the >9,000 ubiquitination interactions involving UBC) to 
construct a physical interaction network and searched for each phospho-peptide the 10 shortest paths linking 
it to the transcriptions factors whose targets are up regulated during MGC formation. We defined 
topological proximity between a phospho-peptide and a transcription factor as the average length of the 10 
shortest path between them. 
All phosphopeptide – transcription factor pairs were then ranked by topological proximity, and a null 
distribution of topological proximity was assessed by computing topological proximity between 1,000 
random pairs of protein. A P-value of significance was then computed for each protein pair, and protein 
pairs were considered as potentially interacting when P<0.01. 
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FDR among the predicted interactions was estimated by computing the ratio of the estimated number of 
false positive to the number of positive for various P-value threshold (Supplementary Figure 7A). The 
estimated FDR for a P=0.01 threshold was of 15%.  
To further ensure the selected interacting pairs were not biased toward proteins with high number of 
interactors, we used a second permutation strategy, testing separately for each member of a pair, whether it 
was closer to its interactor in the PPI network than to a randomly chosen protein. Specifically, a null 
distribution of topological proximity was assessed separately for each transcription factor by computing 
topological proximity between 200 random proteins and the TF. A TF-centered P-value (PTF) was then 
computed for each phosphoprotein-TF pair indicating the probability that a particular genes is involved in TF 
activation. 
Symmetrically, a null distribution of topological proximity was assessed separately for each phosphoprotein, 
and a phosphoprotein-centered P-value (PPhospho) was computed for each pair indicating the likelihood that a 
particular gene is activated by a phosphoprotein. All phosphopeptide – transcription factor pairs with 
PTF<0.05 and PPhospho<0.05 were considered as significant (Supplementary Figures 7B, 7C, and 8). 
 
Ethic statement 
Rats were culled by asphyxiation with CO2 and cervical dislocation and the bones were isolated immediately 
for primary macrophage culture. All procedures were performed in accordance with the United Kingdom 
Animals (Scientific Procedures) Act, 1986. 
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RESULTS 
Study design for combining transcriptional and phosphoproteomic analyses during macrophage multinucleation 
We first identified MGC-specific transcriptomic and phosphoproteomic signatures by focusing on critical 
time points during multinucleation in fusion-competent WKY BMDMs. We compared the transcriptome 
and phosphoproteome profiles of WKY rats BMDMs with LEW BMDMs, which present a markedly reduced 
MGC formation (Figure 1A and B). In the WKY rat BMDMs, macrophage fusion events start to appear 
after 3 days of culture. At day 5 the multinucleation process is well underway with formation of MGCs and 
further culture of these cells lead to almost complete fusion of all cells in the plate at day 7 (Figure 1A). In 
order to capture the dynamics molecular events underlying of MGC formation, we have quantified the 
phosphopeptides by LC-MS/MS and mRNA by RNA-seq at day 3 (mononucleated macrophages) and day 5 
in fusing macrophages. (Figure 1A and B). We have then investigated transcription factors (TF) underlying 
the transcriptional changes through TF motif enrichment analysis (Figure 1C, step [a]). We combined the 
phosphoproteomics and transcriptional data by using a k-shortest-path strategy similar to (30) to investigate 
the link between differentially abundant phosphopeptides and TFs driving transcriptional changes measured 
by RNA-seq during macrophage multinucleation (Figure 1C, step [b]). Briefly, our k-shortest-path strategy 
measures the relatedness of a phosphoprotein to a given TF, as a function of the average distance between 
them in the protein-protein interaction network (see Experimental Procedures). The proposed 
integrative approach thus allows the identification of novel regulators of macrophage multinucleation both at 
the transcriptional and cell-signaling levels. 
 
Transcription factors driven networks underlying the transcriptional changes in multinucleating macrophages  
Clustering and Principal Component Analysis  of RNA-seq profiles revealed major differences in the 
transcriptome of WKY and LEW BMDMs as well as between the onset of fusion (day 3) and during early 
stage of MGC formation (day 5) in the WKY rat. The difference in the LEW transcriptome between day 3 
(D3) and day 5 (D5), however, was of smaller magnitude (Supplementary Figure 1A and B). We 
performed differential expression analysis between D3 and D5 in both strains and observed a stronger 
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change of the transcriptional program measured by RNA-seq in WKY than in LEW (3,976 differentially 
expressed genes vs 2,364 in LEW, Supplementary Table 2); this was mostly due to WKY-specific over-
expression of genes at D5 during the early stage of multinucleated giant cell formation (Figure 2A). We 
first investigated the functional enrichment of differentially expressed genes over the time course (D3 vs D5 
in both strains) and between the rat strains (independently of the time course, Supplementary Figures 
1C and D). We then focused on the identification of the putative regulators of macrophage multinucleation 
by filtering for transcripts specifically up-regulated in early MGC formation. To this aim, we extracted the 
subset of 943 genes whose expression was showing WKY-specific increase during multinucleation (Figure 
2B and see Experimental Procedures). Functional enrichment analysis of these MGC-specific genes 
showed a marked enrichment for glycolysis (P<10-7, false discovery rate (FDR)=0.0002%) and its 
components (glucose, monosaccharide and hexose catabolic processes) as well as response to hypoxia (P<10-
3, FDR=2.6%) (Figure 2C, Supplementary Table 3).  
Transcription factor binding site enrichment analysis revealed that the MGC-specific up-regulated genes 
were most significantly enriched for transcription factor targets of PLAG1 (P<1.1x10-10, FDR<3.6x10-8), 
and HIF-1 complex (P<2.2x10-8, FDR<1.5x10-6) (Figure 2C). We then reconstructed the network of 
enriched TFs and their target genes, which suggested that the effect on glycolytic genes was mostly mediated 
by HIF1 (Figure 2D and Supplementary Table 4). All enrichments were robust to the use of more 




Macrophage multinulceation is associated with increased HIF1-mediated glycolysis 
HIF1 is constitutively expressed in macrophages (Supplementary Figure 2). Given the previously 
established regulatory role of HIF1 in hypoxia-mediated glycolysis (reviewed in (31)), we hypothesized that 
HIF-mediated glycolysis is up-regulated in WKY during MGC formation and is required for spontaneous 
MGC formation. qRT-PCR analysis showed transient mRNA expression of Hif1a (Figure 3A) as well as its 
glycolytic targets (Ldha, Gpi, tpi1, Pfkl, Eno1, Pgk1) peaking at early stage of MGC formation in WKY 
BMDMs (Figure 3B). Given the key role played by LDHA in HIF1-mediated glycolysis (32), we next 
measured LDHA protein levels as readout of HIF1-mediated glycolysis. LDHA over-expression specific to 
the fusion-competent WKY BMDMs at day 5 was confirmed at the protein level by Western Blot analysis 
(Figure 3C). We then inhibited cellular glycolysis by addition of 2-deoxy-D-glucose (2-DG) to the WKY 
BMDM at the onset of fusion (Day 3) and observed decreased expression of glycolytic genes 
(Supplementary Figure 3A), decreased protein amounts of LDHA (Supplementary Figure 3B) as 
well as decreased formation of MGC at day 5 (Figure 3D and 3E), suggesting a role of HIF-mediated 
glycolysis during MGC formation in macrophages. 
 
Phosphoproteome analysis in multinucleating macrophages  
In order to investigate the mechanisms upstream the transcriptional regulation underlying the spontaneous 
multinucleation observed in WKY BMDMs, we characterized phosphorylation sites showing specific 
phosphorylation patterns during MGC formation. We performed titanium dioxide enrichment in protein 
lysates to isolate phosphopeptides (19) from LEW and WKY in BMDM after 3 and 5 days of culture, 
respectively. We then used LC-MS/MS to quantify over 2,000 highly abundant phosphopeptides, among 
which 1006 were reliably detected in at least one condition (see Experimental Procedures). We first 
focused on a subset of 425 phosphopeptides reliably detected in all conditions, for quantitative analysis of 
differential phosphoprotein abundance (Supplementary Table 5). Out of the 425 phosphopeptides, we 
identified 128 differentially phosphorylated peptides at 5% FDR level between LEW and WKY macrophages 
at day 5, but only 17 at day 3, therefore suggesting multinucleation-specific phosphorylations patterns. 
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Similar to the RNA-seq analysis, we further identified a set of 50 peptides specifically phosphorylated or 
dephosphorylated in MGC (i.e., in WKY at day 5 – see Supplementary Figure 4 and Experimental 
Procedures). The expression of this phosphopeptide set across all conditions is shown in Figure 4A. We 
further searched for specific absence/presence patterns in MGC formation and identified 6 phosphopeptides 
that were either specifically present or absent in WKY macrophages at D5 (Supplementary Figure 5A).  
For the large majority of differentially phosphorylated sites, nor mRNA encoding for the protein showed no 
change in expression, suggesting posttranslational modification rather than transcriptional regulation of the 
peptides (Supplementary Figure 5B). This observation was further supported by the low fold changes in 
protein expression, observed when comparing protein abundance in WKY and LEW at the peak of 
multinucleation (Supplementary Figure 5C and Supplementary Table 6). Functional enrichment 
analysis of phosphoproteins showing MGC-specific phosphorylation patterns did not reveal any significant 
enrichment at a 5% FDR threshold. Interestingly however, we noticed 3 poly-phosphate inositol 
phosphatases amongst the set of differentially phosphorylated sites, which were specifically down-
phosphorylated in MGC precursors (Supplementary Figure 6A-F) This observation was supported by a 
marginal trend toward enrichment for poly-phosphate inositol related phosphatases (P=0.02, FDR=18%). 
These findings are consistent with the previously reported role of poly-phosphates inositol phosphorylation 
in RANKL-mediated osteoclast multinucleation (33, 34), (summarized in Supplementary Figure 6G). 
 
Integrative analysis of TF-driven networks and phosphoproteome data in multinucleating macrophages  
In order to investigate how the observed changes in the phosphoproteome can underlie the transcriptomic 
reprogramming of macrophages during multinucleation and characterize the resulting regulatory effects, we 
examined the molecular links between differentially phosphorylated peptides and transcription factors using 
known interaction networks. We focused on expressed transcription factors showing specific change in 
activity during macrophage multinucleation (WKY D5, Supplementary Figure 2). We used a k-shortest 
path algorithm (35) to find the 10 shortest path linking phosphoprotein-transcription factor pair in the 
protein-protein interaction network. Firstly, the length of the 10 shortest paths was used to rank pairs 
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according to their topological proximity in the protein-protein interaction network (Figure 4C). We then 
used a two way random sampling strategy to test each pair for higher-than-random proximity in the network 
topology (see Experimental Procedures and Supplementary Figures 7B-C). This approach led to the 
identification of 25 putative phosphoprotein–TF relationships, including six direct phosphoprotein-TF 
interactions (Supplementary Figure 8). These interactions are likely to be indicative of putative 
regulators of transcription factors showing increased activity during macrophage multinucleation (i.e., 
differentially expressed TFs targets during macrophage multinucleation). Our shortest path analysis 
identified LRRFIP1 as the only transcription factor undergoing direct phosphorylation during MM. LRRFIP1 
was also the most strongly expressed of MGC-specific TFs (Figure 4D), and its predicted target genes 
showed functional enrichment for cytoskeleton organization (Figure 4E, Supplementary Table 7, see 
Experimental Procedures). This led us to prioritize LRRFIP1 for further analyses. In addition, this 
analysis identified DNMT1 and SMARCA4 as phosphoproteins that were predicted to be functionally related 
to a large number of TFs showing differential activity during multinucleation (after accounting for possible 
connectivity bias, see Supplementary Figure 8), which were followed up through validation experiments. 
Of note, Vimentin (VIM) was also identified by our shortest path analysis as a MGC specific phosphoprotein, 
in close proximity to a large number of MGC specific TFs. However, a strong decrease in the significance of 
Vimentin was observed when accounting for connectivity bias in the shortest path analysis 
(Supplementary Figures 7C and 8), suggesting that the significance of could be driven by its high 
connectivity alone (257 interactors in Biogrid). This observation led us to discard Vimentin as a candidate 
for follow up.  
 
Identification and validation of novel determinants of macrophage multinucleation 
Leucine rich repeat (in FLII) interacting protein 1 (LRRFIP1) is a transcriptional repressor binding GC-rich 
motif sequences previously described as a regulator of Toll-Like Receptor response and Nf-kappaB activity 
(36). LRRFIP1 showed MGC-specific differential phosphorylation (Figure 4A and 5A-D) and enrichment 
for predicted targets in the MGC-specific genes assessed by RNA-seq (P<3.8x10-7, FDR<9.9x10-6, Figure 
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2C). Moreover, the MGC-specific up-regulated transcripts that are LRRFIP1-targets were enriched for 
cytoskeleton organization (P<0.0002, FDR<0.3%, Figure 5E), a key biological process associated with 
macrophage fusion and multinucleation events (37) and showed a strong over-expression at day 5 (Figure 
5F). We therefore hypothesized that phosphorylation of LRRFIP1 might play a role in macrophage 
multinucleation through a down-regulation of its repressor activity. To test this hypothesis, we knocked-
down LRRFIP1 expression in fusion-competent WKY BMDMs at the onset of fusion (i.e., at D3) and 
observed an up-regulation of its transcriptional targets (Figure 5G) associated with a marked decrease in 
macrophage multinucleation (Figure 5H and I). Although these data validate the role of LRRFIP1 in 
macrophage multinucleation, the decrease of multinucleation following LRRFIP1 knock down suggests that 
the role of LRRFIP1 in multinucleation is independent of the transcriptional control of its target genes. 
 
In addition to LRRFIP1, our integrated analysis of TFs-networks and phosphoproteome data in 
multinucleating macrophages also revealed SMARCA4 and DNMT1 as potential regulators of the 
transcriptional program in these cells (Figure 4C). Both phosphoproteins showed close interactions with 
more than seven TFs active during multinucleation (including HIF1), suggesting a potential role in the 
regulation of the multinucleation transcriptional program (Figure 4C and Supplementary Figure 8). 
SMARCA4 is a transcriptional activator also known as BRG1, previously shown to regulate the expression of 
the well established macrophage multinucleation marker, CD44 (10), whereas DNMT1 is a DNA methyl-
transferase involved in transcriptional repression via methylation of transcription factor binding site (38). 
We therefore hypothesized that SMARCA4 and DNMT1 were required for HIF1-mediated transcriptomic 
activation of glycolysis and more generally for the transcriptomic reprogramming occurring during 
macrophage multinucleation. To test this hypothesis, we performed siRNAs mediated knock-down of 
SMARCA4 and DNMT1 in fusion competent WKY macrophages at the onset of fusion (D3), and observed a 
reduction of transcription glycolytic enzymes (Ldha, GP1, Tpi, Pfkl, Pgk1) at day 5 together with a significant 
reduction of multinucleation (Figure 6). For SMARCA4 but not DNMT1, measurement of LDHA levels 
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following siRNA knock down, confirmed the reduction of protein abundance at the protein level 
(Supplementary Figure 9). 
 
Taken together our integrative analysis of transcriptional and phosphoproteomics data in multinucleating 
macrophages revealed complex cellular pathways as well as key regulators (HIF1A, LRRFIP1, SMARCA4 




In the present study, we have taken advantage of a spontaneous multinucleation occurring in the BMDMs of 
the inbred WKY rat and employed an integrative strategy to identify new pathways involved in macrophage 
multinucleation. We show that early MGC formation is regulated at metabolic and cell signaling levels. We 
further demonstrate that, by combining RNA-seq and phosphoproteome, novel determinants of macrophage 
multinucleation can be identified. 
At the metabolic level, we showed that macrophage multinucleation required activation of HIF1-mediated 
glycolytic transcription, mediated partly by dephosphorylation of SMARCA4 and DNMT1. HIF1 has been 
reported previously as a potential target in osteoporosis due to its effect on osteoclast mediated bone 
resorption and osteoclast activity (39), suggesting the hypothesis that HIF1-mediated effects in 
multinucleation might also be relevant for the downstream osteoclast activity and bone resorption. In cancer, 
a similar activation of HIF1 under normoxic conditions has been described as the Warburg effect (40). This 
observation suggests some shared metabolic features between giant cell formation and tumorigenesis. Our 
integrative framework also identified PSMA5, MAP3K1, and EEF1A2 as putative regulators of HIF1 
activation. PSMA5 is a component of the proteasome complex, that is responsible of down-regulation of 
HIF1 activity under normoxic condition through fast degradation of HIF1A (41), whereas MAP3K1 is an 
activator of the JNK kinase pathway that leads to activation of HIF1 and Nf-kappaB (42).  
At a cell signaling level, we observed significant changes in phosphorylation of several phosphatidyl-inositol 
and inositol phosphatase during early multinucleation in macrophages. Phosphatidyl-inositol (PI) 
phosphorylation has also been linked to cytoskeletal regulation and membrane trafficking (45) and PI kinase 
such as PI3K have been previously linked to osteoclast differentiation (33). Our finding corroborates the 
already proposed role of PI3K in osteoclast differentiation and further suggests that increased osteoclast 
formation is maintained by downregulation of the activity of PI phosphatases Ipp5d, Ipp5e and Synj1. 
Our integrative analysis of phosphoproteome and transcriptome using the k-shortest path analysis identified 
three novel regulators of macrophage multinucleation, LRRFIP1, DNMT1 and SMARCA4. We showed that 
LRRFIP1 acts as a repressor of the cytoskeleton re-organization occurring during macrophage 
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multinucleation and suggested that its phosphorylation is responsible for the downregulation of its 
transcriptional activity during MGC formation. The decrease in multinucleation that we observed after 
knock-down of LRRFIP1 indicates that LRRFIP1 is still active during multinucleation independently of its 
transcriptional repressor activity. Interestingly, beside its transcriptional repressor activity, LRRFIP1 was 
also shown to play a role in transduction of TLR4 signalling by competing with FLII for binding to MYD88, 
leading to activation of Nf-Kappa B (46). Hence, phosphorylation of LRRFIP1 may act by switching 
LRRFIP1 from a transcriptional repressor activity to a signalling role in interaction with MYD88 leading to 
giant cell formation via Nf-KappaB activation. SMARCA4 (also known as brahma-related gene-1, Brg1) is a 
mammalian homologue of SWI/SNF chromatin-remodeling factor subunits that can regulate both 
transcriptional activation and repression. SMARCA4 is mutated or deleted in numerous cancer cell lines 
(47–49), leading to the altered expression of genes that influence cell proliferation and metastasis. 
Interestingly, the promoter of CD44, a previously established macrophage multinucleation marker (10), is 
hypermethylated in cells that have a genetic deletion of SMARCA4 (50). In keeping with this, the de-
phosphorylation of DNMT1, a DNA (cytosine-5-)-methyltransferase 1, suggests modification of its 
enzymatic activity that could result in aberrant methylation levels in the DNMT1-target promoters during 
multinucleation. The role of DNA methylation in macrophage multinucleation is unknown and future 
studies will be pivotal in establishing the methylation-driven transcriptional control of macrophage 
multinucleation. Beyond the identification of novel determinants of multinucleation, the specific effect of 
phosphorylation sites on the functional properties of these and on cell fusion preceding macrophage 
multinucleation remain to be determined. In summary, we integrated transcriptome and phosphoproteome 
data to investigate regulatory networks underlying multinucleation and prioritized new candidate genes and 
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Figure 1: Analysis pipeline. Primary macrophages from WKY and LEW are derived from the bone 
marrow after 3 day of culture and show a marked phenotypic difference in multinucleation and MGC 
formation (Figure 1A). To understand the determinants of spontaneous macrophage multinucleation, we 
measure the macrophage transcriptome and phospho-proteome at day 3 (mononuclear and differentiated 
BMDMs) and in MGC precursors (day 5). MGC precursor-specific molecular signatures are next identified 
by determining transcriptional changes unique to WKY day 5 BMDMs (Figure 1B) and by characterizing 
multinucleation-specific transcription factors through transcription factor binding site enrichment analysis 
(1C, step a). Finally, multinucleation-specific transcription factors and phosphopeptides are integrated by 
identifying pairs in closer than random vicinity in the protein interaction network (1C step b). 
 
Figure 2: Transcriptomic signature of macrophage multinucleation uncovers a role of HIF1-
mediated glycolysis in MGCs. (A) The number of up (red arrow) and down (blue arrow) regulated 
transcripts between each pair of condition (strain of rat and time of culture). (B) the overlap of genes up 
regulated at D5 in both strains and genes up regulated in WKY at D5 and highlights the group of MGC 
precursor specific genes. Panel C shows GO and TFBS enrichment for the set of MGC specific genes. Panel 
D shows the network of TF found in the enrichment analysis (red) with MGC specific genes that among 
their top 200 predicted target (blue). Node size reflects number of neighbours.  Glycolysis genes and are 
highlighted in green. Panel E shows the transcript level expression of the top 3 TF found in the Enrichment 
analysis. 
 
Figure 3: HIF1 mediated glycolysis is essential for macrophage multinucleation. Panel A shows 
expression of HIF1a in macrophages from WKY and LEW across time points. Panel B shows expression of 
HIF1a targets Ldha, Gpi, Tpi1, Pfkl, Pgk1 and Eno1 in macrophages from WKY and LEW and across time 
points. Panel C shows western blot of Ldha at day 3 and day 5 in WKY and LEW respectively. Panel D and 
E show the effect of 2 Deoxy glucose treatment on multinucleation of WKY BMDM. 
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Figure 4: Phosphoproteome reprogramming and prediction of new regulators of MGC 
transcriptomic reprogramming via shortest path analysis. Panel A shows the heatmap of 
phosphopeptide expression across all conditions for the set of peptides harboring MGC specific 
phosphorylation pattern. For each phospho-peptides, abundance is shown relative to the median across all 
samples and in log2 scale.  Grey spots represent missing quantification of the peptide. Panel B shows –log10 
P-values of Gene Ontology enrichment of phospho-protein showing MGC specific (de)phosphorylation 
patterns. Panel C shows the topological proximity score between MGC specific phospho-peptides and 
transcription factors, based on 10-shortest path analysis. Stronger color indicates higher topological 
proximity in the protein-protein interaction network. Only the scores that are significant at a 5% nominal P-
value are displayed (pairs among the top 5% closest pairs of the PPI network). MGC specific 
phosphoprotein-transcription factors pairs that have a direct connection in the PPI network are highlighted 
in green. Panel D shows expression (FPKM) of transcription factors with over-represented targets among 
MGC specific transcripts. Panel E shows the strongest over-represented Gene ontology among the targets of 
each transcription factor. Bars heights reflect –log10 P-values of enrichment. 
 
Figure 5: LRRFIP1 a new regulator of MGC formation. Panel A and C show extracted ion 
chromatograms of the two LRRFIP1 phosphopeptides exhibiting differential phosphorylation across time 
points in both strains. On each graph the blue, green and red curve show the intensity of the three main 
isotopic peaks. Panel B and D show the associated quantification of normalized phosphoprotein abundance. 
Panel E represents GO enrichment of LRRFIP1 direct interactors (salmon) and predicted targets specifically 
up-regulated in MGC (turquoise). Panel F shows the expression of LRRFIP1 predicted targets over time in 
both WKY and LEW during multinucleation. Panel G shows the effect of LRRFIP1 knockdown on its 
predicted targets. Panel H and I highlight the role of LRRFIP1 in macrophage fusion by showing the 
reduction of macrophage multinucleation following LRRFIP1 Knock down. 
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Figure 6: Effect of DNMT1 and SMARCA4 knock-down on glycolysis and multinucleation. 
Panels A, B and C show the effect of siRNA knock down of DNMT1 on multinucleation and glycolysis in 
WKY macrophages. A comparison of cell cultures over time and quantifications of multinucleation are 
shown in panel A and C. Panel B shows the effect of knock down of DNMT1 on glylotyic gene expression at 
day 5. Panel D, E and F show the effect of siRNA knock down of SMARCA4 on multinucleation and 
glycolysis in WKY macrophages. A comparison of cell cultures over time and quantifications of 
multinucleation are shown in panel D and F. Panel C shows the effect of knock down of SMARCA4 on 
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